| Target Price | $5.11 |
| Price | $3.46 |
| Potential |
47.63%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Raia Drogasil Adr 2027 .
The average Raia Drogasil Adr target price is $5.11.
This is
47.63%
register free of charge
$6.47
87.04%
register free of charge
$3.50
1.20%
register free of charge
|
|
| A rating was issued by 20 analysts: 16 Analysts recommend Raia Drogasil Adr to buy, 3 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Raia Drogasil Adr stock has an average upside potential 2027 of
47.63%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 8.52 | 9.40 |
| 13.84% | 9.78% | |
| EBITDA Margin | 10.59% | 8.23% |
| 1.81% | 22.25% | |
| Net Margin | 2.93% | 3.34% |
| 5.06% | 13.96% |
15 Analysts have issued a sales forecast Raia Drogasil Adr 2026 . The average Raia Drogasil Adr sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Raia Drogasil Adr EBITDA forecast 2026. The average Raia Drogasil Adr EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Raia Drogasil Adr Analysts have issued a net profit forecast 2026. The average Raia Drogasil Adr net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.15 | 0.18 |
| 7.14% | 20.00% | |
| P/E | 20.46 | |
| EV/Sales | 0.89 |
14 Analysts have issued a Raia Drogasil Adr forecast for earnings per share. The average Raia Drogasil Adr EPS is
This results in the following potential growth metrics and future valuations:
Raia Drogasil Adr...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


